Author

J. D. Ramsey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Pharmacology & Toxicology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:drug response / drug discovery· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

C. Lim· 5 shared D. Hwang· 5 shared A. V. Kabanov· 4 shared M. Sokolsky· 3 shared A. Kabanov· 2 shared H. M. Atkins· 2 shared H. Yuan· 2 shared M. Sokolsky-Papkov· 2 shared

Activity by Year

2021-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersCancer Biology

C. Lim

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Combination of Polymeric Micelle Formulation of TGFβ Receptor Inhibitors and Paclitaxel Produce Consistent Response Across Different Mouse Models of TNBC

N. Vinod, D. Hwang, S. C. Fussell, T. C. Owens, O. C. Tofade, S. Copling, J. D. Ramsey, P. D. Radler, H. M. Atkins, E. E. Livingston, J. A. Ezzel, M. Sokolsky, H. Yuan, c. perou, A. Kabanov

This study combines polymeric micelle-formulated TGFβ receptor inhibitors with Paclitaxel to show consistent anti-tumor effects across multiple TNBC mouse models.

bioRxiv · Jun 14, 2023 · PreprintCancer Biology

High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast Cancer

C. Lim, D. Hwang, M. Yazdimamaghani, H. M. Atkins, H. Hyun, Y. Shin, J. D. Ramsey, C. M. Perou, M. Sokolsky-Papkov, A. Kabanov

This study evaluates high-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple-negative breast cancer, showing improved therapeutic outcomes and immune response.

bioRxiv · Aug 12, 2022Cancer Biology

Nanoformulated Remdesivir with Extremely Low Content of Poly(2-oxazoline) - Based Stabilizer for Aerosol Treatment of COVID-19

J. D. Ramsey, I. E. Stewart, E. A. Madden, C. Lim, D. Hwang, M. T. Heise, A. J. Hickey, A. V. Kabanov

bioRxiv · Jan 21, 2022Bioengineering

Bioequivalence Assessment of High-Capacity Polymeric Micelle Nanoformulation of Paclitaxel and Abraxane(R) in Rodent and Non-Human Primate Models Using a Stable Isotope Tracer Assay

D. Hwang, N. Vinod, S. L. Skoczen, J. D. Ramsey, K. S. Snapp, S. A. Montgomery, M. Wang, C. Lim, J. E. Frank, M. Sokolsky-Papkov, Z. Li, H. Yuan, S. T. Stern, A. V. Kabanov

Biomaterials · Nov 1, 2021Peer-reviewedPharmacology & Toxicology

Drug-dependent morphological transitions in spherical and worm-like polymeric micelles define stability and pharmacological performance of micellar drugs

C. Lim, J. D. Ramsey, D. K. Hwang, S. C. M. Teixeira, C.-D. Poon, J. D. Strauss, M. Sokolsky, A. V. Kabanov

This study evaluates how the morphology of polymeric micelles affects their pharmacological performance, finding that spherical micelles are more effective for drug delivery when drugs are loosely associated.

bioRxiv · Jun 10, 2021Pharmacology & Toxicology

Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq-guided combination with sapanisertib

C. Lim, T. Dismuke, D. Malawsky, J. D. Ramsey, D. Hwang, V. L. Godfrey, A. V. Kabanov, T. R. Gershon, M. Sokolsky

This study improves CDK4/6 inhibitor therapy for medulloblastoma by combining nanoparticle delivery with scRNA-seq-guided identification of sapanisertib, enhancing survival in mice.

bioRxiv · Jun 9, 2021Cancer Biology